RDNT - RadNet, Inc.
NASDAQ
->
Healthcare
->
Diagnostics & Research
Los Angeles,
United States
Type: Equity
RDNT price evolution
RDNT
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $741.68 | $526.98 | $342.57 | |
| Short term investments | ||||
| Net receivables | $229.29 | $224.51 | $223.84 | $189.05 |
| Inventory | ||||
| Total current assets | $1016.25 | $1004.72 | $795.83 | $579.28 |
| Long term investments | $100.84 | $97.03 | $92.71 | |
| Property, plant & equipment | $1310.62 | $1276.96 | $1240.54 | $1200.43 |
| Goodwill & intangible assets | $793.03 | $781.17 | $770.08 | |
| Total noncurrent assets | $2224.7 | $2173.73 | $2111.2 | |
| Total investments | $100.84 | $97.03 | $92.71 | |
| Total assets | $3275.34 | $3229.42 | $2969.55 | $2690.47 |
| Current liabilities | ||||
| Accounts payable | $383.61 | $386.27 | $345.07 | $358.85 |
| Deferred revenue | $4.46 | $4.47 | $4.65 | |
| Short long term debt | $83.47 | $78.34 | $73.95 | |
| Total current liabilities | $470.13 | $474.2 | $427.89 | $437.45 |
| Long term debt | $996.27 | $1634.78 | $1444.79 | $1417.16 |
| Total noncurrent liabilities | $1662.38 | $1464.34 | $1439.66 | |
| Total debt | $1718.24 | $1523.13 | $1491.12 | |
| Total liabilities | $2380.03 | $2136.58 | $1892.23 | $1877.11 |
| Shareholders' equity | ||||
| Retained earnings | -$82.13 | -$85.34 | -$82.36 | -$79.58 |
| Other shareholder equity | -$1.84 | -$8.06 | -$13.94 | -$12.48 |
| Total shareholder equity | $880.97 | $872.96 | $630.7 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $342.57 | $127.83 | $134.61 | $102.02 |
| Short term investments | ||||
| Net receivables | $189.05 | $185.33 | $140.45 | $135.42 |
| Inventory | ||||
| Total current assets | $579.28 | $367.18 | $324.26 | $270.42 |
| Long term investments | $92.71 | $57.89 | $42.23 | $34.53 |
| Property, plant & equipment | $1200.43 | $1169.48 | $1068.54 | $883 |
| Goodwill & intangible assets | $770.08 | $783.89 | $570.42 | $525.27 |
| Total noncurrent assets | $2111.2 | $2066.72 | $1734.21 | $1516.23 |
| Total investments | $92.71 | $57.89 | $42.23 | $34.53 |
| Total assets | $2690.47 | $2433.91 | $2058.47 | $1786.66 |
| Current liabilities | ||||
| Accounts payable | $358.85 | $125.78 | $287.47 | $250.69 |
| Deferred revenue | $4.65 | $4.02 | $10.7 | $39.26 |
| Short long term debt | $73.95 | $70.01 | $76.62 | $108.16 |
| Total current liabilities | $437.45 | $466.72 | $374.78 | $398.11 |
| Long term debt | $1417.16 | $839.34 | $1321.17 | $1076.75 |
| Total noncurrent liabilities | $1439.66 | $1475.73 | $1337.53 | $1130.24 |
| Total debt | $1491.12 | $1513.47 | $1397.79 | $1184.91 |
| Total liabilities | $1877.11 | $2100.91 | $1712.32 | $1528.35 |
| Shareholders' equity | ||||
| Retained earnings | -$79.58 | -$82.62 | -$93.27 | -$118 |
| Other shareholder equity | -$12.48 | -$20.68 | -$20.42 | -$24.05 |
| Total shareholder equity | $630.7 | $333 | $228.9 | $165.74 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $461.14 | $459.71 | $431.71 | $420.38 |
| Cost of revenue | $389.72 | $387.59 | $356.59 | |
| Gross Profit | $69.34 | $69.99 | $44.12 | $63.79 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $34.98 | $35.14 | $32.78 | $34.31 |
| Operating income | $34.85 | $11.34 | $29.48 | |
| Income from continuing operations | ||||
| EBIT | $25.56 | $11.62 | $15.48 | |
| Income tax expense | $4.33 | $2.46 | -$1.86 | $0.73 |
| Interest expense | -$22.59 | $26.08 | $16.27 | $16.61 |
| Net income | ||||
| Net income | $3.21 | -$2.98 | -$2.78 | -$1.86 |
| Income (for common shares) | -$2.98 | -$2.78 | -$1.86 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1616.63 | $1430.06 | $1315.08 | $1071.84 |
| Cost of revenue | $1395.24 | $1264.35 | $1123.27 | $965.9 |
| Gross Profit | $221.39 | $165.72 | $191.8 | $105.94 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $134.36 | $119.35 | $89.57 | $70.25 |
| Operating income | $87.03 | $46.36 | $102.23 | $35.68 |
| Income from continuing operations | ||||
| EBIT | $76 | $70.85 | $88.12 | $31.94 |
| Income tax expense | $8.47 | $9.36 | $14.56 | $0.9 |
| Interest expense | $64.48 | $50.84 | $48.83 | $45.88 |
| Net income | ||||
| Net income | $3.04 | $10.65 | $24.73 | -$14.84 |
| Income (for common shares) | $3.04 | $10.65 | $24.73 | -$14.84 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$2.98 | -$2.78 | -$1.86 | |
| Operating activities | ||||
| Depreciation | $49.77 | $47.08 | $46.25 | |
| Business acquisitions & disposals | -$30.66 | -$3.53 | -$8.59 | |
| Stock-based compensation | $4.75 | $11.9 | $5.41 | |
| Total cash flows from operations | $116 | $17.09 | $88.92 | |
| Investing activities | ||||
| Capital expenditures | -$46.68 | -$57.41 | -$40.06 | |
| Investments | ||||
| Total cash flows from investing | -$184.26 | -$77.34 | -$60.94 | -$48.65 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.36 | $218.39 | $0.07 | |
| Net borrowings | $181.78 | -$2.98 | -$31 | |
| Total cash flows from financing | $400.07 | $176.11 | $228.3 | -$35.47 |
| Effect of exchange rate | $0.04 | -$0.07 | -$0.04 | -$0.12 |
| Change in cash and equivalents | $406.35 | $214.7 | $184.41 | $4.69 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $3.04 | $10.65 | $24.73 | -$14.84 |
| Operating activities | ||||
| Depreciation | $189.49 | $184.72 | $170.66 | $154.71 |
| Business acquisitions & disposals | -$24.95 | -$1.44 | -$1.44 | -$1.64 |
| Stock-based compensation | $26.79 | $23.77 | $25.2 | $12.4 |
| Total cash flows from operations | $220.86 | $146.42 | $149.49 | $233.76 |
| Investing activities | ||||
| Capital expenditures | -$176.52 | -$115.55 | -$214.94 | -$124.61 |
| Investments | ||||
| Total cash flows from investing | -$201.47 | -$246.95 | -$221.51 | -$126.24 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $245.97 | $0.29 | $0.49 | |
| Net borrowings | -$43.99 | $94.25 | $93.54 | -$43.58 |
| Total cash flows from financing | $195.63 | $93.65 | $104.67 | -$45.56 |
| Effect of exchange rate | -$0.29 | $0.11 | -$0.07 | -$0.1 |
| Change in cash and equivalents | $214.74 | -$6.77 | $32.59 | $61.85 |
News
Fundamentals
| Market cap | $3.60B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 73.98M |
| Revenue | $1.77B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$4.41M |
| Revenue Q/Q | 14.72% |
| Revenue Y/Y | N/A |
| P/E ratio | -816.56 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 2.03 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$0.06 |
|---|---|
| ROA | -0.15% |
| ROE | N/A |
| Debt/Equity | 2.98 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.16 |
| Quick ratio | N/A |